Biologic Specimen and Data Repository Information Coordinating Center

Funding Opportunity: NHLBI R21 RFA-HL-17-022

This funding opportunity is to support meritorious exploratory research relevant to the NHLBI mission using the biospecimen collections that are stored in the NHLBI Biorepository and that are available through BioLINCC. The next application due date is October 17, 2019.

For more information on RFA-HL-17-022 please visit:
https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-17-022.html
and
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-17-494.html

New Study: SPRINT (data and specimens)

A new study, Systolic Blood Pressure Intervention Trial (SPRINT), has been posted to BioLINCC. Data and specimens from this study are available for requests.

The SPRINT-POP data, based on the primary outcome paper and previously available for request through the BioLINCC website, have been incorporated into this SPRINT full study data release.

Funding Opportunities Added

New information regarding secondary data and/or biospecimen analysis funding opportunities from NHLBI, NIDDK, and FDA has been added to the funding opportunities page. These NIH Exploratory (R21) grant funding opportunities may be applicable to research using BioLINCC resources. Additionally included is an NHLBI released Notice of Special Interest (NOSI) on Data Science R01 applications. Please see the funding opportunities page, which includes links to the NIH grant announcements, for more information.

Novel Evaluation of GenTAC Images is Available

The Imaging Core Lab of the National Registry of Genetically Triggered Thoracic Aortic Aneurysms (GenTAC) is now considering applications from researchers who have obtained GenTAC data through BioLINCC and who wish to have additional or novel evaluation of GenTAC images beyond the image readings obtained under the original GenTAC study protocol. The application form, instructions, and contact information for the Imaging Core Lab will be made available for request upon approval and fulfillment of a GenTAC data request through BioLINCC.

FAQ for RFA-HL-17-022 now available

The RFA-HL-17-022 funding opportunity now has a FAQ available here: https://www.nhlbi.nih.gov/grants-and-training/funding-opportunities-and-contacts/all-funding-opportunity-announcements-1745

Funding Opportunity: NHLBI R21 PAR-17-004

This funding opportunity is to stimulate the use of existing human datasets for well-focused secondary analyses to investigate novel scientific ideas or new models, systems, tools, methods, or technologies that have the potential for significant impact on biomedical or biobehavioral research in areas relevant to the NHLBI mission. The next application due date is February 22, 2019.

For more information on PAR-17-004 please visit:
https://grants.nih.gov/grants/guide/pa-files/PAR-17-004.html

New BioLINCC Manuscript

A new open-access paper about BioLINCC metrics and results is now available on PLOS ONE:
Giffen CA, Wagner EL, Adams JT, Hitchcock DM, Welniak LA, Brennan SP, Carroll LE. “Providing researchers with online access to NHLBI biospecimen collections: The results of the first six years of the NHLBI BioLINCC program”.

Notice of Addition of AIDS Application Due Dates for RFA-HL-17-022

AIDS application due dates have been added to the Funding Opportunity Announcement for RFA-HL-17-022 "Maximizing the Scientific Value of the NHLBI Biorepository: Scientific Opportunities for Exploratory Research (R21)". The next application due date is January 7, 2020.

For more information, please visit: https://grants.nih.gov/grants/guide/notice-files/NOT-HL-17-565.html